Histamine Receptor 2 Antagonists as Enhancers of Anti-Tumour Immunity
Condition(s):CancerLast Updated:February 8, 2023Completed
Hide Studies Not Open or Pending
Condition(s):CancerLast Updated:February 8, 2023Completed
Condition(s):Gastroesophageal Reflux Disease (GERD)Last Updated:February 8, 2016Completed
Condition(s):Gastroesophageal Reflux Disease (GERD)Last Updated:April 25, 2022Completed
Condition(s):Peanut AllergyLast Updated:February 2, 2022Completed
Condition(s):Coronary Artery Disease; Drug Interaction PotentiationLast Updated:July 6, 2018Completed
Condition(s):Multiple Myeloma; Renal Impairment; Neoplasms, Plasma Cell; Neoplasms by Histologic Type; Neoplasms; Paraproteinemias; Blood Protein Disorders; Hematologic DiseasesLast Updated:March 28, 2022Not yet recruiting
Condition(s):Glioblastoma Multiforme (GBM) WHO Grade IVLast Updated:October 26, 2017Completed
Condition(s):Cesarean Section ComplicationsLast Updated:July 14, 2020Completed
Condition(s):Gastro Esophageal RefluxLast Updated:January 19, 2023Active, not recruiting
Condition(s):Autonomic Failure; Orthostatic HypotensionLast Updated:January 18, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.